ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm (1040) is an AI-enabled medical device from Anumana, Inc., listed by FDA (510(k), K253801) with a decision date of 2026-04-07. Review panel: Cardiovascular.
| FDA submission number | K253801 |
|---|---|
| Pathway | 510(k) |
| Company | Anumana, Inc. |
| Review panel (specialty) | Cardiovascular |
| FDA decision date | 2026-04-07 |
| Decision | Substantially Equivalent |
| Product code | SHP |
| Classification | Cardiac Amyloidosis Machine Learning-Based Notification Software |
| Device class | 2 |
| Regulation number | 870.2380 |
| Review time (calendar days) | 130 |
| Applicant country | US |
Official FDA database record · FDA AI-enabled device list
More devices from Anumana, Inc. · All Cardiovascular AI devices · Full device index
Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.